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Abstract: Among Oceania’s population of 35 million
people, the greatest number living in poverty currently
live in Papua New Guinea (PNG), Fiji, Vanuatu, and the
Solomon Islands. These impoverished populations are at
high risk for selected NTDs, including Necator americanus
hookworm infection, strongyloidiasis, lymphatic filariasis
(LF), balantidiasis, yaws, trachoma, leprosy, and scabies, in
addition to outbreaks of dengue and other arboviral
infections including Japanese encephalitis virus infection.
PNG stands out for having the largest number of cases
and highest prevalence for most of these NTDs. However,
Australia’s Aboriginal population also suffers from a range
of significant NTDs. Through the Pacific Programme to
Eliminate Lymphatic Filariasis, enormous strides have
been made in eliminating LF in Oceania through
programs of mass drug administration (MDA), although
LF remains widespread in PNG. There are opportunities to
scale up MDA for PNG’s major NTDs, which could be
accomplished through an integrated package that com-
bines albendazole, ivermectin, diethylcarbamazine, and
azithromycin, in a program of national control. Australia’s
Aboriginal population may benefit from appropriately
integrated MDA into primary health care systems. Several
emerging viral NTDs remain important threats to the
region.
Introduction
The neglected tropical diseases (NTDs) represent the most
common infections of the world’s poorest people, a group
sometimes known as ‘‘the bottom billion’’ [1,2]. These tropical
infections trap people in poverty through their adverse effects on
worker productivity, pregnancy outcomes, and child cognition and
development [1,2]. Recently, the World Health Organization
(WHO) developed a list of 17 NTDs [3], with an expanded list of
these conditions on the website of PLOS Neglected Tropical Diseases
[4]. Since 2008, efforts have been made to review and describe the
differences in the etiologies, prevalence, and disease burden of the
major NTDs according to their regional distribution [5–12]. In
this respect, the prevalence and distribution of the NTDs in the
Americas [5–7], Europe [8], sub-Saharan Africa [9], China and
East Asia [10], India and South Asia [11], Central Asia [12], and
the Middle East and North Africa [13] have been previously
reviewed. Here we summarize current knowledge on the
prevalence and distribution of the NTDs in the region known as
Oceania, which includes Australia, New Zealand, Melanesia, and
the Polynesian and Micronesian islands of the Pacific. This review
was conducted using the online database PubMed from 1997 to
2012 with the Medical Subject Headings, the specific diseases
listed in the WHO’s first report on NTDs, and the list from PLOS
Neglected Tropical Diseases [3,4], as well as the geographic regions
and countries of Oceania. Reference lists of identified articles and
reviews were also manually searched, as were databases from the
WHO (http://www.who.int), including the Weekly Epidemiological
Record.
Poverty in Oceania
Approximately 35 million people live in Oceania, a region of
tropical and sub-tropical islands in the South Pacific Ocean
(Figure 1). Almost two-thirds of the population (22.3 million) lives
on the continent of Australia, followed in descending order by
Papua New Guinea (6.8 million), New Zealand (4.4 million), Fiji
(0.9 million), and the Solomon Islands (0.5 million) (Table 1). In
all, of the dozens of island nations that comprise Oceania, more
than 99% live in eight nations including those listed above,
together with French Polynesia, New Caledonia, and Vanuatu.
Despite their proximity to one another, the nations of Oceania
represent a diverse array of economies. Australia and New
Zealand each rank near the top of the United Nations human
development indices (HDIs, 2nd and 5th, respectively) [14],
whereas more than one-third of the population of Papua New
Guinea (PNG) live below the World Bank poverty figure of
US$1.25 per day [15]. PNG has an HDI of 153, placing it near the
bottom of the global HDIs and is one of only four non-sub-
Saharan countries (the others being Afghanistan, Haiti, and
Yemen) with HDIs below 150 [14]. Fiji, Vanuatu, and the
Solomon Islands also have HDIs of 100 or lower [14]. However,
extremely impoverished indigenous groups are also found within
the two wealthiest countries in the region, Australia and New
Zealand. For instance, Aboriginal Australians, numbering nearly
half a million, earn average incomes amounting to 62% of non-
indigenous residents [16]. Within Australia, indigenous Australians
reside in greatest numbers in New South Wales and Queensland,
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although the Northern Territory has the highest percentage of
Aboriginal people [17].
Throughout the world’s low- and middle-income countries,
and even among wealthy countries, the NTDs disproportionately
affect people living in poverty, but especially those in extreme
poverty [5–13]. Here we provide an overview of the major NTDs
affecting people living in poverty in Oceania, with an emphasis
on the eight nations with populations that exceed 200,000 and
comprise more than 99% of the number of people living in this
region.
Helminth Infections
Helminth infections may represent the most prevalent NTDs in
Oceania, led by hookworm and lymphatic filariasis (LF; Tables 2
and 3), although significant numbers of cases of ascariasis,
trichuriasis, strongyloidiasis, and hymenolepiasis are also present.
Soil-Transmitted Helminth Infections
Hookworm infection is possibly the most prevalent NTD in
Oceania, with an estimated 5.5 million cases, comprising roughly
Figure 1. Map of West Pacific Islands. http://www.worldofmaps.net/en/oceania/map-pacific/map-west-pacific-islands.htm, accessed May 20, 2012.
doi:10.1371/journal.pntd.0001755.g001
Table 1. The Countries and Population of Oceania and the Percentage Living in Poverty.
Nation Total Population
Percentage of Population
Living below US$1.25 per Day
Percentage of Incidence of Povertya
or Population below the Threshold
for Relative Povertyb
Percentage of
Population below
50% Median Income
Australia 22.3 million N/A N/A N/A
Papua New Guinea 6.8 million 37.5 [15] N/A N/A
New Zealand 4.4 million N/A N/A 11 [123]
Fiji 860,000 31.0 [15] 35 [124] N/A
Solomon Islands 538,000 N/A 22.7 [125] N/A
French Polynesia 270,764 N/A 27.6 [126] N/A
New Caledonia 254,000 N/A N/A 17 [127]
Vanuatu 239,000 9.2 [128] N/A N/A
aFiji, Solomon Islands.
bFrench Polynesia.
doi:10.1371/journal.pntd.0001755.t001
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1% of the world’s cases of hookworm infection [18]. Most of
Oceania’s hookworm cases are concentrated in PNG, where
according to some estimates three-quarters of the population is
infected, followed by Fiji, the Solomon Islands, and Vanuatu
[18]. Necator americanus is the predominant hookworm species in
PNG, comprising 100% of the hookworms in some areas [19,20]
(Supplemental Table 1 in Text S1) It is not known whether
Ancylostoma duodenale is also present in PNG, but during the
Australian Hookworm Campaign of 1919–1924, PNG was also
studied, and N. americanus was found to be virtually the only
hookworm detected [21]. In contrast, both N. americanus and A.
duodenale may have been present historically in Australia among
both white and Aboriginal communities. Today, hookworm is
found almost exclusively among Aboriginal Australians in
Western Australia and the Northern Territory, where A. duodenale
is believed to be the sole species [21]. During the 1990s, isolated
Aboriginal populations in northwest Australia exhibited hook-
worm prevalence rates that exceeded 75% (with high rates of
hookworm anemia) [22], but no recent published data are
available. However, it is likely that mass drug administration
(MDA), although provided inconsistently, has reduced the
hookworm prevalence among selected communities [23]. A
unique eosinophilic enteritis syndrome caused by the dog
hookworm, Ancylostoma caninum, has also been reported from
north Queensland, and elsewhere in Australia, although it is not
considered a significant public health problem [24].
Among the other soil-transmitted helminth nematode infections,
ascariasis and trichuriasis are much less common in Oceania.
However, trichuriasis appears to be a common geohelminth in Fiji,
accounting for almost one-half of the number of cases in Oceania,
while large numbers of cases also appear in the Solomon Islands
and Vanuatu [18]. PNG accounts for much of the ascariasis in
Oceania [25], followed by Fiji, the Solomon Islands, and Vanuatu
[18]. Strongyloidiasis is an important soil-transmitted helminth
infection in Oceania, although no overall prevalence data are
available. Among Aboriginal Australian populations, the high
rates of Strongyloides stercoralis infection may partly reflect a high
incidence of human T-cell lymphotropic virus type 1 (HTLV-1)
infections, which predisposes to this parasite. Prevalence rates of S.
stercoralis infection as high as 60% have been reported [26]. A high
mortality from S. stercoralis and HTLV-1 co-infections can result
because of Strongyloides hyperinfection [27]. In a study of
Strongyloides hyperinfection in central Australia among Australian
Aboriginals, 77% were found to be HTLV-1 positive [28]. In
PNG, S. stercoralis infection also occurs [26], as well as a unique
form of strongyloidiasis caused by S. fuelleborni kellyi [25]. This form
of the infection can be vertically transmitted, and has been
associated with swollen belly syndrome in the Gulf and Madang
provinces [25]. In one study, 27% of children tested positive for
Strongyloides, with 81% of these children under the age of one [25].
Strongyloides-infected populations in both Australia and PNG
may therefore benefit from MDA programs using ivermectin [26].
Outside of PNG, S. stercoralis infection has recently been described
in medical volunteers in the Solomon Islands [29]. Sporadic cases
of human Trichostrongylus infections have also been reported [30–
32].
Hymenolepis nana infection has been reported as a common soil-
transmitted cestodiasis among Aboriginal communities in Aus-
tralia and PNG [23,33], although the overall prevalence is not
known. In Australia’s Northern Territory, MDA with albendazole
was found to be ineffective at reducing the prevalence of this
infection [23].
Lymphatic Filariasis (LF)
Next to hookworm and possibly strongyloidiasis, LF is likely to
be the most prevalent helminthic NTD in Oceania. Although LF is
Table 2. Major Helminth Infections in Oceania.
Diseasea Estimated Number of Cases in Oceania Percentage of Global Disease Burden Refs
Hookworm infection 5.5 million 1% [18,129]
Lymphatic Filariasis 2.7 million 2% [34,130]
Trichuriasis 1.2 million ,1% [18,129]
Ascariasis 1.2 million ,1% [18,129]
aNumbers for the hookworm infection, trichuriasis, and ascariasis were derived by multiplying the current population of each nation as reported in Table 1 by the
percentage of people infected as reported in reference [18].
doi:10.1371/journal.pntd.0001755.t002
Table 3. Geographic Distribution of the Major Helminthic NTDs in Oceania.
Diseasea
Country of Largest
Prevalence (# of Cases)
Country of Second
Largest Prevalence
(# of Cases)
Country of Third Largest
Prevalence (# of Cases)
Country of Fourth Largest
Prevalence (# of Cases) Refs
Hookworm Papua New Guinea (4.9 million) Fiji (318,000) Solomon Islands (192,000) Vanuatu (88,000) [18]
Trichuriasis Fiji (541,000) Solomon Islands (338,000) Papua New Guinea (204,000) Vanuatu (150,000) [18]
Ascariasis Papua New Guinea (748,000) Fiji (215,000) Solomon Islands (135,000) Vanuatu (59,000) [18]
Lymphatic filariasis Papua New Guinea (2.7 million) [34]
aNumbers for the hookworm infection, trichuriasis, and ascariasis were derived by multiplying the current population of each nation as reported in Table 1 by the
percentage of people infected as reported in reference [18].
doi:10.1371/journal.pntd.0001755.t003
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found throughout Oceania, PNG is the only nation with a
published national prevalence estimate [34]. In 1997 it was
estimated that approximately 2.7 million people were infected
[34], accounting for more than 2% of the global disease burden.
Since then, MDA has been implemented with diethylcarbamazine
citrate (DEC) plus albendazole [35]. On Lihir Island, MDA in
conjunction with vector control led to a 75% reduction in the
seroprevalence of microfilarial antigenemia [36,37] and evidence
of reduced transmission [38]. Despite these measures, the WHO
reported in 2010 that, of the 5.6 million people in PNG who would
benefit from empirical chemotherapy for LF, only 6.3% had been
covered nationally [39].
Throughout most of Oceania, LF elimination efforts through
MDA are underway through the auspices of the Pacific
Programme to Eliminate Lymphatic Filariasis (PacELF) [40].
MDA has now ceased in Vanuatu because the prevalence has
dropped below the 1% threshold. Ongoing post-MDA surveillance
will be required to certify elimination efforts in this country [40].
On Ouvea Island, New Caledonia, a survey indicated that
approximately one-third of the population was antigenemic prior
to launching their PacELF program [41]. As of 2010, mapping of
LF is complete in New Caledonia, but no MDA program has been
implemented [39]. Fiji and French Polynesia currently have active
MDA programs underway with 100% coverage [36]. On Fiji’s
Kadavi Island, DEC has reduced the percent testing positive for
microfilaremia by 90% [42]. In PNG, PacELF has not yet been
implemented at a national level. The remaining countries—
Australia, New Zealand, and Solomon Islands—are considered
non-endemic [36]. Of interest, the Solomon Islands achieved
elimination largely through a program of vector control rather
than MDA [43].
Zoonotic Helminth Infections
Two emerging helminth zoonoses, cystic echinococcosis
(hydatid disease) and cysticercosis, are of concern. While several
eradication programs have been implemented on the mainland of
Australia, Echinococcus granulosus remains widespread among sheep
and macropods [44,45]. In Tasmania, following a successful
eradication program, only one echinococcosis case of mainland
Australian origin has been reported since 1974 [46]. Although
echinococosis has been declared eliminated in New Zealand,
reports of hydatid disease presentations have occurred in
Auckland, likely through importation [46,47]. Cysticercosis is
not endemic in Australia, but it has occurred in recent
immigrants and Australians traveling to endemic regions
[48,49]. In PNG, indigenous and West Papuan refugees living
along the border were found to have asymptomatic Taenia solium
infections, but more comprehensive studies are needed to
recognize the true prevalence of infection [50]. Trichinella
psuedospiralis infections have been isolated from humans in
Tasmania [51].
Protozoan Infections
The major intestinal protozoan infections in Oceania are
amebiasis, balantidiasis, cryptosporidiosis, and giardiasis (Supple-
mental Table 5). In Australia, these infections can dispropor-
tionately affect Aboriginal populations. However, no overall
prevalence estimates are available. Among urban Australians, an
analysis of seroprevalence of men who have sex with men (MSM)
indicated that HIV+ MSM have a higher seroprevalence of
Entamoeba sp. infection than HIV2 MSM [52,53]. It is uncertain
whether this represents infection with the pathogenic species
Entamoeba histolytica or the saprophyte Entamoeba dispar. In New
Caledonia, E. histolytica was found among hospitalized patients
with hepatic abscesses [54]. Epidemic foci of Balantidium coli
infection have been reported from swine-producing areas of
PNG, and an outbreak of balantidiasis was described after a
typhoon on Truk resulted in contamination of ground and
surface water with pig feces [55]. Giardiasis is also common
among Aboriginal Australians and presumably other populations
in Oceania [22]. Albendazole used for deworming these
populations may also have had some activity against Giardia
[56,57]. Among non-Aboriginal communities, exposure to this
pathogen has been identified in waterborne outbreaks, and is
believed to be common among children in daycare settings [58–
60]. In New Zealand, Giardia parasites were found in some people
presenting with acute gastrointestinal illness [61]. Chagas disease
is not endemic in any of the nations in the Oceania region.
However, immigration of over 80,000 immigrants from Latin
America to Australia in 2006 is likely to have resulted in the
importation of 1,000 or more cases [62]. When combining the
permanent arrivals from Argentina, Brazil, Chile, El Salvador,
and Uruguay, as well as the resident population of Latin
American immigrants from Columbia and Peru, the potential
number of infected individuals in this group has been estimated
to be 16 per 1,000 in Australia [63].
Bacterial and Fungal NTDs
The major bacterial NTDs include the treponematoses, yaws,
and congenital syphilis; intracellular bacterial infections including
active trachoma, leprosy, Buruli ulcer, bartenellosis, bovine
tuberculosis (TB), and brucellosis; and leptospirosis and cholera
(Supplemental Tables 2–4, 6). Mycetoma is a fungal NTD in the
region.
Treponematoses
Yaws has not been eliminated from Oceania despite its
susceptibility to MDA with azithromycin, or azithromycin used
together with DEC in programs of PacELF [64,65] (Supple-
mental Table 6). While great strides have been made in
eliminating yaws, this chronic infection remains endemic in
PNG, the Solomon Islands, and Vanuatu, although advanced
cases are rare [66]. Infections occur among schoolchildren in
PNG, including a high proportion of cases in the secondary stage
(46%) [67], while an unspecified number of cases have been
serologically detected in the Solomon Islands and elsewhere
[68,69]. Studies on school children from the island of Tanna in
Vanuatu have recently confirmed a resurgence of yaws [70]. As
part of WHO’s elimination program for congenital syphilis,
PNG, the Solomon Islands, and Fiji have reported surveillance
data on this infection, with PNG exhibiting the highest
prevalence [71]. A prior WHO report combined seven studies
of maternal syphilis seroprevalence from 1997 to 2003 for
Vanuatu. Studies of syphilis among pregnant women were also
performed in New Caledonia with seroprevalence between 7%
and 12.4% [72].
Active Trachoma, Leprosy, and Other Intracellular
Bacterial NTDs
Trachoma infections occur in Australia, PNG, Fiji, Vanuatu,
and the Solomon Islands (Supplemental Table 2). The most recent
released data from the WHO in 2003 indicated the greatest
number of active trachoma cases were in PNG (16,289), followed
by Australia (8,800), Fiji (1,865), and the Solomon Islands (1,403)
[73]. Additional data indicated that the prevalence of active
trachoma in Fiji, the Solomon Islands, and Vanuatu are similar
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(22%–23%) [74]. Aboriginal Australians living in remote commu-
nities also suffer from high prevalence of trachoma [75]. The
SAFE (surgery, antibiotics, facial cleanliness, and environmental
control) program has been implemented among Aboriginal
Australians communities, with some reductions in overall preva-
lence [76].
The prevalence of leprosy is again highest in PNG, with 281
reported new cases in 2010 in addition to an estimated 580
existing cases [77]. Among Aboriginal Australians in the early
1950s, the incidence of diagnosis of leprosy was 270 per 100,000,
but had fallen to 4/100,000 in the Northern Territory by 1997
[78]. This decrease was attributed to widespread use of the BCG
vaccine in Aboriginal populations since 1958 [78]. Buruli ulcer,
another mycobacterial infection, is endemic in some specific
locations in Southeastern Australia and Queensland, with focal
outbreaks being reported [79,80]. Bartonellosis caused by
Bartonella henselae has been detected in blood donors from
Australia and New Zealand, as well as in children with hepatic
abscesses in New Caledonia [81–84]. Bovine TB is present New
Zealand, but it represents a small proportion of the overall TB
incidence in Oceania [85,86]. There were also cases of bovine TB
originating in PNG that were detected in Australia [86].
Brucellosis is reportable in Australia, with 32 cases documented
in 2009 [87].
Leptospirosis
Leptospirosis is endemic in Oceania, with both sporadic cases
and outbreaks being reported. In Australia, there has been a
significant increase in the incidence of leptospirosis over the past
decade, with the heaviest occupational burden among banana
farmers and dairy workers [88]. In 2009, Australia reported 149
cases of leptospirosis nationally, with over 75% of the cases
occurring in Queensland [87]. In New Zealand, 81 cases of
leptospirosis were reported in 2010, with an elevated incidence in
Ruapehu, the West Coast District, and Hawke’s Bay [89,90]. In
New Caledonia, an outbreak of leptospirosis occurred during
heavy rainfalls and flooding attributed to La Nina [91], while
American Samoa was found to have a high prevalence of the
disease [92]. Previously in Fiji, Vanuatu, and French Polynesia,
Leptospira icterohemorrahgiae was identified as the dominant species
[93,94].
Cholera
Cholera outbreaks have been noted in several nations of
Oceania. In 2009, an outbreak occurred in PNG, eventually
reaching 8,997 cases by the end of 2010, with the highest
incidence in the Madang Province [95,96]. In addition, an
outbreak was reported from a resort in Fiji [97]. In Australia, four
cases, all imported were reported in 2009.
Arboviral Infections
The major arboviral infections in Oceania are the flavivirus
infections caused by dengue, Japanese encephalitis (JE), and
Murray Valley encephalitis (MVE), as well as mosquito-transmit-
ted alphavirus infections, Ross River virus (RRV) and Barmah
Forest virus (BFV).
Overall, the incidence of dengue is underreported in Oceania.
In Australia, dengue infection and associated mortality were first
identified in Charters Towers in northern Queensland in 1897
[98]. There have been reports of dengue in Fiji, French
Polynesia, New Caledonia, the Solomon Islands, and Vanuatu
prior to 1950 [99]. In 2010, the Western Pacific Region of the
WHO (WPRO) reported national incidence data for dengue in
Australia, Fiji, French Polynesia, New Caledonia, New Zealand,
and Vanuatu (Supplemental Table 4) [100]. French Polynesia,
New Caledonia, Vanuatu, and Australia accounted for more
than 90% of the reported cases within the Western Pacific
subregion [100]. In Australia, North Queensland reports the
greatest number of cases [100], which included an outbreak
during the 2008–2009 wet season [101]. Dengue is not endemic
in New Zealand, and in 2010 all 51 reported cases in New
Zealand were of foreign origin, with Vanuatu accounting for
12% of those cases [87,100]. In addition to WPRO surveillance,
a seroprevalence study indicated that dengue has also emerged in
the Solomon Islands [102]. The overall epidemiology of dengue
is perhaps least understood in PNG, although evidence for the
infection has been found in adults and children with febrile
illness [103].
Within Oceania, JE and MVE are found primarily in Australia
and PNG. JE emerged during the 1990s in PNG and in the Torres
Strait of Australia [104]. The reports of JE in the Torres Straight
islands may have resulted from movement of migratory birds or
wind-blown mosquitoes from PNG [105]. The JE isolates from
PNG and Torres Strait share .99% sequence identity [106]. In
Australia, MVE is endemic in north and southeastern Australia,
with four cases reported 2009 [87,107], while in PNG MVE was
identified in mosquito isolates, but no human seroprevalence data
are available [106].
In Australia, RRV infection has been reported periodically,
but outbreaks have become more intense and frequent [108]. In
2009, 4,786 cases were reported in Australia, with nearly half in
Queensland [87]. In PNG, no national prevalence data have
been compiled, but in the Southern Highlands Province
antibody prevalence for RRV was 59% [109]. After an apparent
disappearance in the years following a 1979–1980 outbreak,
RRV has reemerged in Fiji [110]. BFV is unique to Australia,
and is distributed throughout the continent with the highest
incidence in Queensland [111]. In 2008, the national incidence
of BFV was found to have increased 34% over the mean rate of
the previous 5 years [111]. Within Australia, RRV and BFV
account for most of the reported arbovirus disease notifications
[101].
Ectoparasitic Infections
Scabies is a major endemic ectoparasitic infection among
Aboriginal Australians and in other Oceanic nations. In
Australia, pre-treatment prevalence levels exceeded 30% among
indigenous children in some communities [112,113], with high
rates of secondary infections of streptococcal pyroderma [112–
114]. MDA treatment with ivermectin in a village in PNG was
found to reduce scabies prevalence by two-thirds to 26% [115].
In the Solomon Islands, scabies prevalence among children was
reduced with ivermectin treatment to 0.7% [116]. In two studies
undertaken in Fiji, the burden of scabies in schoolchildren was
between 18.5% and 32% [117,118]. A study in Vanuatu
demonstrated increased efficacy of ivermectin over benzyl
benzoate in treating childhood scabies [119]. Myiasis has also
been reported in New Zealand, acquired both in the country and
internationally [120].
Discussion
Several important NTD trends have emerged in the Oceania
region.
1. MDA. Proof of concept for achieving success in MDA in
Oceania has been obtained through the PacELF with high
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levels of LF treatment coverage in Fiji, French Polynesia, and
New Caledonia, and the possible elimination of LF in Vanuatu
[40]. The Solomon Islands has previously eliminated LF
through vector control [43]. As such successes have not yet
extended to PNG, it remains the most endemic in Oceania
[36,40]. A concerted effort in PNG for LF elimination in the
coming years would be consistent with efforts by the Global
Programme to Eliminate LF’s to eliminate this disease as a
public health problem globally by 2020 [40,121]; there is an
urgency to ensure that the government of PNG has the
adequate human capital and technical support as well as
sufficient funding to expand MDA and elimination efforts.
Currently, there are no comprehensive post-MDA surveil-
lance programs in place for any LF-endemic country in the
region. The development and implementation of surveillance
plans for all countries will be important to monitor areas of
persistent or re-emerging LF [40]. Additional targets for MDA
in Oceania could include soil-transmitted helminth infections,
which could be linked to LF elimination efforts through the
addition of albendazole to DEC, as well yaws elimination
through the addition of azithromycin to DEC [64,65]. The
recent finding by Mitja et al. that single-dose azithromycin is
as effective as benzathine benzyl penicillin for the treatment of
yaws in PNG is an important breakthrough on that front [64].
There are opportunities to scale up these options, especially in
PNG [64].
2. PNG. More than any other nation in Oceania, PNG stands out
with respect to having the largest number of cases and high
prevalence of several key NTDs, including N. americanus
hookworm infection, strongyloidiasis, hymenolepiasis, LF,
balantidiasis, yaws, trachoma, leprosy, and possibly scabies
and dengue and other arboviral infections, as well as outbreaks
of cholera [18,25,33,34,55,64,73,77,103,115]. PNG could
benefit enormously from a national control program of
integrated MDA that simultaneously targets many of these
NTDs using the drugs albendazole, ivermectin, DEC, and
azithromycin. Therefore, there are opportunities to collect the
safety data needed to determine the suitability of combining
these medicines in an integrated MDA package, together with
financial support for implementation linked to operational
research.
3. Aboriginal populations in Australia. Australia’s Aboriginal popula-
tion also suffers from disproportionately high rates of NTDs,
including strongyloidiasis, leprosy, and scabies, and possibly
hookworm infection [26,73,112,113]. There may be opportu-
nities for integrating MDA packages as outlined above for PNG
into programs of primary care for Australia’s Aboriginal
populations.
4. Arboviral infections. The impact of arboviral infections, especially
emerging dengue and RRV in PNG, is still not well understood
[106]. Dengue, JE, and RRV could emerge as important NTD
pathogens in Oceania in the coming decade. Malaria is
endemic in regions of PNG, the Solomon Islands, and
Vanuatu. In the Solomon Islands, malaria vector control was
responsible for a substantial reduction of LF [122]. Current
malaria programs implemented by the Pacific Malaria
Initiative Support Centre (PacMISC) in Vanuatu and the
Solomon Islands as well as the Global Fund in PNG are
promising tools for reducing the burden of several mosquito-
borne diseases, particularly in PNG, where Anopheles transmit
both malaria and LF. Integration of monitoring and evaluation
M&E in these programs and in non-endemic nations will
provide assistance in controlling the rising threat of arboviral
pathogens in the future.
In summary, tremendous strides have been made in controlling
and eliminating selected NTDs in Oceania, but mostly through
PacELF. There is an urgent need to extend these successes to all of
the major NTDs throughout the region but especially in PNG and
among Aboriginal Australians.
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Learning Points
N The efficacy of the Pacific Programme to Eliminate
Lymphatic Filariasis (PacELF) has been demonstrated in
Oceania, but enhanced efforts are still required in Papua
New Guinea and New Caledonia.
N While proof of concept for NTD management in Oceania
was shown by PacELF, novel MDA programs need to be
crafted, especially in Papua New Guinea and Aboriginal
Australia, in order to target specific NTDs indigenous to
neglected populations in these regions, including
hookworm, strongyloidiasis, and other soil-transmitted
helminthiases, yaws, trachoma, and scabies.
N While the impact of emerging arboviral infections,
including dengue, Japanese encephalitis, and Ross River
virus infection, is still not well understood, these diseases
could also emerge as important NTDs in the coming
decade.
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